Bio-Techne Total Revenue

As of the most recent data (March 2026), TECH shows a total revenue of $1.2B. That compares with $1.2B in the prior-year period — up 0.2% year over year. That is below the Healthcare sector average of $110B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TECH's total revenue is now $1.2B (was $1.2B) — a 0.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bio-Techne is outperforming or lagging.

The Healthcare sector average total revenue is about $110B. Bio-Techne is at $1.2B, which is lower that average. That is roughly 98.9% below the sector mean. Use the comparison chart on this page to see how TECH stacks up against individual peers as well.

Tracking TECH's total revenue over time shows whether Bio-Techne is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2B That compares with $1.2B in the prior-year period — up 0.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total revenue page, Stockcircle has Bio-Techne's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total revenue (currently $1.2B) with ownership activity and broader fundamentals.